Which of the following is NOT a function of a virtual manufacturer?

A virtual manufacturer typically operates differently compared to traditional manufacturers in the pharmaceutical industry. One of the main characteristics of a virtual manufacturer is that it does not physically produce drugs itself. Instead, it might focus on coordinating production with third-party manufacturers, managing contracts, or handling various other functions related to drug development and distribution.

In this context, holding inventory of finished drugs is not within the typical scope of a virtual manufacturer. Instead, this responsibility is usually managed by another entity, such as a traditional manufacturer or a distributor. Virtual manufacturers are more likely to engage in activities such as contracting others for production and distribution, and they might own the New Drug Applications (NDA) or Abbreviated New Drug Applications (ANDA), but they do not usually hold physical inventory themselves.

This distinction is crucial in understanding the operational characteristics of a virtual manufacturer compared to traditional manufacturers or distributors.